No Time to Lose: G20 Leadership Needed in Research to End TB
March 2017 - Victory over antimicrobial resistance (AMR) requires an end to the world’s deadliest infectious disease: tuberculosis (TB). Each year, TB kills more people than any other single infectious agent, and drug-resistant forms of TB account for one in three AMR deaths. However, inadequate, outdated tools—the result of the paucity of resources spent on TB research and development (R&D)—compromise the fight against TB. Creating a world free of TB by 2035, as envisioned by the World Health Organization (WHO) End TB Strategy and echoed by the United Nations Sustainable Development Goals, requires a substantial increase in funding for TB R&D.
An Activist’s Guide to Tuberculosis Diagnostic Tools
February 2017 - Understanding tuberculosis (TB) diagnosis is critical to understanding why the world is currently failing to end TB. Nearly half of people with TB—over 4 million per year—are undiagnosed, leaving them ill and at risk of death and with the potential to transmit disease to others. Closing this massive gap will require much better use of the current diagnostic methods, as well as research into faster, simpler, more accurate, and less expensive options.
An Activist’s Guide to Tuberculosis Diagnostic Tools provides an overview of the different tests and strategies for detecting TB, including their benefits and limitations. The guide also makes recommendations for how activists and clinicians can contribute to improved TB diagnosis.